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ABSTRACT
Cytosolic glutathione S-transferase (GST) enzymes participate in several cellular processes in addition
to facilitating glutathione conjugation reactions that eliminate endogenous and exogenous toxic com-
pounds, especially electrophiles. GSTs are thought to interact with various kinases, resulting in the
modulation of apoptotic processes and cellular proliferation. The present research used a combination
of in silico and in vitro studies to investigate protein–protein interactions between the seven most
abundant cytosolic GSTs—GST alpha-1 (GST-A1), GST alpha-2 (GST-A2), GST mu-1 (GST-M1), GST mu-2
(GST-M2), GST mu-5 (GST-M5), GST theta-1 (GST-T1) and GST pi-1 (GST-P1)—and Mitogen-activated
protein kinase 8 (MAPK8) and Apoptosis signal-regulating kinase 1 (ASK1). MAPK8 and ASK1 were
chosen as this study’s protein interaction partners because of their predominant role in electrophile or
cytokine-induced stress-mediated apoptosis, inflammation and fibrosis. The highest degree of
sequence homology or sequence similarity was observed in two GST subgroups: the GST-A1, GST-A2
and GST-P1 isoforms constituted subgroup1; the GST-M1, GST-M2 and GST-M5 isoforms constituted
subgroup 2. The GST-T1 isoform diverged from these isoforms. In silico investigations revealed that
GST-M1 showed a significantly higher binding affinity to MAPK8, and its complex was more structur-
ally stable than the other isoforms, in the order GST-M1>GST-M5>GST-P1>GST-A2>GST-A1>GST-
M2>GST-T1. Similarly, GST-A1, GST-P1 and GST-T1 actively interacted with ASK1, and their structural
stability was also better, in the order GST-T1>GST-A1>GST-P1>GST-A2>GST-M5>GST-M1>GST-
M2. To validate in silico results, we performed in vitro crosslinking and mass spectroscopy experiments.
Results indicated that GST-M1 interacted with GST-T1 to form heterodimers and confirmed the pre-
dicted interaction between GST-M1 and MAPK8.
Abbreviations: GST: Glutathione S-Transferase; MAPK: Mitogen-Activated Protein Kinase; ASK:
Apoptosis Signal-Regulating Kinase; MD: Molecular Dynamics; RMSD: Root-Mean-Square Deviation;
RMSF: Root-Mean-Square Fluctuation; RoG: Radius of Gyration; PCA: Principal Component Analysis; ED:
Essential Dynamics.
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Cytosolic glutathione S-transferase (GST) enzymes are
involved in multiple cellular processes, in addition to catalys-
ing glutathione conjugation reactions that eliminate
endogenous and exogenous toxic compounds, especially
electrophiles (Adler et al., 1999; G€ulçin, Scozzafava, Supuran,
Akıncıoglu, et al., 2016; G€ulçin, Scozzafava, Supuran, Koksal,
et al., 2016; Hayes & Pulford, 1995; Hayes et al., 2005; Taslimi
et al., 2020; Temel et al., 2018). Members of the cytosolic
GST family share sequence similarity among themselves and
with members of the mitochondrial GST family (Gulçin et al.,
2018; Nebert & Vasiliou, 2004; T€urkan et al., 2020). Structure-
wise, Cytosolic GST enzymes comprise two important
domains and two critical binding sites: the N-terminal thiore-
doxin-like domain is responsible for glutathione binding, i.e.
at G-sites, and the C-terminal alpha-helical domain and the
N-terminal domain both harbour the hydrophobic ligand-
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binding site, i.e. at H-sites (Lian, 1998). GSTs exhibit versatility
in binding to inhibitors or substrates at H-sites, as demon-
strated in previous experiments involving specific ligands (Lo
Bello et al., 1997; Oakley et al., 1997).
GSTs can act as ligandins (Lu & Atkins, 2004) since they
are thought to inhibit some of the key proteins—c-JUN N-
terminal kinase-1 (JNK1) or mitogen-activated protein kinase
8 (MAPK8), apoptosis signal-regulating kinase 1(ASK1)—
responsible for inducing the apoptotic process. MAPK8 and
ASK1 are key factors in the apoptotic processes due to elec-
trophile-induced oxidative stress and cytokine-mediated
inflammatory response (Adler et al., 1999; Cho et al., 2001).
The hypothesised inhibition of MAPK8 and ASK1 by GSTs
may occur directly or indirectly, via protein–protein inter-
action with the target proteins or by limiting the consequent
activation of those target proteins (Cho et al., 2001; Gilot
et al., 2002; Wu et al., 2006). However, it is unknown whether
this interaction is due to one specific GST isoform (often
reported to be GST-P1) or is exhibited by all cytosolic GSTs.
It is unclear which GST isoform might show an increased
binding affinity towards either MAPK8 or ASK1. Unravelling
the binding affinities, interaction patterns and structural sta-
bility of various GST isoform complexes with either MAPK8
(JNK1) or ASK1 is crucial since these studies could provide
insights into the targeted covalent inhibition (TCI) or tar-
geted noncovalent inhibition (TNCI) of this family of
enzymes. The latter further contributes to the development
of inhibitors that can modulate cellular responses such as
apoptosis, fibrosis and inflammation (Ma et al., 2007, 2014).
TCI and TNCI strategies are pivotal to identify the most
promising leads, based on three extensive in silico screening
techniques—structure-based virtual screening (SBVS), ligand-
based virtual screening (LBVS) and drug repurposing of FDA
approved drugs for another pharmacological indication.
Physiologically (observed at 20–40 nM concentrations), cyto-
solic GSTs are mostly present as dimers, with only traces of
monomers to be found (Fabrini et al., 2009), and it has been
proposed that both forms interact with MAPKs (Adler et al.,
1999). GST isoforms may form heterodimers or homodimers
(Fabrini et al., 2009), and the binding affinities of such inter-
actions indicate their readiness to form heterodimers in the
absence or abundance of a specific GST isoform. Insights
into the protein–protein interactions of each cytosolic GST
isoform with MAPK8 and ASK1 also illustrates the probability
of each active isoform being in either the glutathione-bound
or target protein-bound forms (Mollica et al., 2016).
Understanding protein–protein affinities will also help to
evaluate the role of particular GST isoforms expressed in spe-
cific tissues and prompting electrophile-induced stress-medi-
ated apoptosis via the ASK1–JNK1 pathway (Adler et al.,
1999; Cho et al., 2001; Ma et al., 2014; Wu et al., 2006)
The present study investigated the protein–protein inter-
actions of the seven most abundant cytosolic GST isoforms,
which are predominantly expressed in hepatocytes and hem-
atopoietic cells together with MAPK8 and ASK1. Combined in
silico and in vitro studies identified the most feasible and
pertinent interacting partner (Table 1). To the best of our
knowledge, this was the first time that such a hybrid in
silico–in vitro study had been used to identify the suitable
binding and interaction partners for these seven cytosolic
GST isoforms. The systematic approach proposed here could
serve as the basis for identifying the interaction and binding
partners of other enzymes, thus, opening a gateway for
numerous experimental studies.
2. Material and methods
A schematic workflow of the present study’s methodology is
depicted in Figure 1.
2.1. In silico investigations
2.1.1. Preparation of the input protein sequence dataset,
comparative protein sequence alignment and
phylogenetic tree construction
The amino acid sequences of seven cytosolic GST isoforms
and members of the MAPK family were selected and
retrieved from the Universal Protein Resource (UniProt) data-
base (Table 1) (Bateman et al., 2017). Multiple sequence
alignment (or comparative protein sequence alignment) was
performed using the Clustal Omega web server (Sievers
et al., 2011), which is based on a progressive method, fol-
lowed by the construction of a phylogenetic tree using four
methods, namely, the Unweighted Pair Group Method with
Arithmetic Mean (UPGMA), Maximum Parsimony (MP),
Minimum Evolution (ME) and Neighbour-Joining (NJ).These
four methods were combined to obtain a more reliable, con-
sensus-based phylogenetic tree. The statistical significance of
the phylogenetic tree’s topology was evaluated using a boot-
strap analysis with a 1000-iterative tree construction, using
the Molecular Evolutionary Genetics Analysis (MEGA) pack-
age, Version 4 (Hall, 2013).This analysis produced the follow-
ing sequential and evolutionary details: (i) number of
conserved sites (C), (ii) number of variable sites (V), (iii) num-
ber of parsimony-informative sites (Pi), (iv) number of
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singleton sites (S), (v) pairwise evolutionary distances, (vi)
overall mean average or overall mean distances, (vii) closest
homolog and (viii) homologs which were found in neigh-
bouring clades or groups.
2.1.2. In silico interactions between GSTs and MAPK8
or ASK1
2.1.2.1. Protein–protein docking. We investigated the inter-
molecular interactions of seven cytosolic GST isoforms with
MAPK8 and with ASK1 in terms of their critical interacting
key residues (responsible for the formation of predicted
protein–protein complexes), types of intermolecular interac-
tions (mainly hydrogen bonds and disulphide bonds),
modes of binding, binding orientation, hotspot residues
(residues frequently interacting with interaction partners)
and estimated binding affinities. Three-dimensional protein
structures were retrieved from the Research Collaboratory
for Structural Bioinformatics-Protein Data Bank (RCSB-PDB)
(Berman et al., 2000). The experimental structural informa-
tion for the seven cytosolic GST isoforms is available in the
Supporting Information (Tables S1–S7). The easy interface
option in the High Ambiguity Driven Protein–Protein
Docking (HADDOCK) web portal (De Vries et al., 2010) was
then used to perform protein–protein docking calculations
for the GST isoforms with ASK1 or MAPK8. Finally, the best
HADDOCK docking solution for each protein–protein com-
plex (isoform’s interaction) was selected based on two
important criteria:(i) a significant or higher number of popu-
lations or docking solutions (largest cluster) or docking sol-
utions for that complex and (ii) higher docking or
HADDOCK score, indicating strong binding affinity between
the complex’s two proteins. The detailed methodology for
using the HADDOCK programme is given in the Supporting
Information (Methodology 1). Further, the essential struc-
tural parameters of these predicted protein–protein com-
plexes were obtained using PROtein binDIng enerGY
prediction (PRODIGY) and an analysis of the structural sum-
maries in the Protein Data Bank (PDBSum) web services (De
Beer et al., 2014). These structural parameters include inter-
face area, interface volume, number of interfacial amino
acid residues, number of salt bridges, number of disulphide
bonds, number of intermolecular hydrogen bonds, number
of nonbonded contacts, estimated free energy of binding
(DG) and details of interfacial and noninterfacial contacts.
As with the intermolecular interactions between GSTs and
MAPK8 or ASK1, intramolecular interactions studies were
also performed and analysed among the GST isoforms
themselves, using the methods given in Supporting
Information (Methodology 1).
2.1.3. Identification of hotspot residues using in silico
alanine scanning mutagenesis
To compute the hotspot residues of the interactions
between GSTs and ASK1 or MAPK8, the complexes displaying
strong and significant binding affinity and structural stability
in the HADDOCK web portal (De Vries et al., 2010) were sub-
mitted to the DrugScorePPI webserver (Kr€uger & Gohlke,
2010). This webserver uses a knowledge-based scoring func-
tion to scan the interface residues between two proteins in a
protein–protein complex and mutate those residues into ala-
nine. Subsequently, the DGWT (wild type) and DGMT (mutant
type) interface residues to alanine were calculated, and
finally, DDG indicates the change in the free energy of bind-
ing calculated for each of the interface residues between
Figure 1. Study’s schematic workflow. Tool and database explanations and abbreviations are given in the main text.
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GSTs and ASK1 or MAPK8. A positive value represents a pos-
sible hotspot residue which might be involved in protein–-
protein interactions. This analysis revealed the potential
hotspot residues on GST isoforms that are crucial for inter-
molecular interactions with MAPK8 and with ASK1.
2.1.4. Molecular dynamics simulation of GSTs with MAPK8
and ASK1
We used the Gromacs software package, version 5.0.5 (Van Der
Spoel et al., 2005), and a period of 20 ns to perform molecular
dynamics (MD) simulations of the interactions between
selected GST isoforms and MAPK8 or ASK1. We used Optimized
Potentials for Liquid Simulations (OPLS-AA/L) all-atom force
field (Robertson et al., 2015), with the default cubic box parame-
ters for MD simulations, employing the following standard
steps:(i) preparation of input files for MD simulation such as
conversion of a Protein Data Bank (PDB) file to a Gromacs-for-
matted input file (GRO), creation of a topology file describing
the geometrical parameters of a protein–protein complex,
namely, charge group identification, bond-length, bond-angle,
proper and improper torsion angles and positional restraint
files to avoid steric clashes between the complex’s atoms when
higher force MD simulation was applied; (ii) definition of the
box dimension around the protein–protein complex; (iii) add-
ition of water molecules (in this case, we used a Single Point
Charge Extended (SPCE) to the box); (iv) addition of counterions
(positive or negative ions to neutralise the system); (v) energy
minimisation using the steepest-descent approach and involv-
ing two-phase equilibration (phase1 using a constant Number
of particles, Volume and Temperature or NVT;phase2 using con-
stant Number of particles, Pressure and Temperature or NPT)
followed by the production of MD simulations for the protein–-
protein complexes using a period of 20 ns. The results were ana-
lysed using various built-in Gromacs package functions, such as
Root Mean Square Deviations (RMSD), Root Mean Square
Fluctuation (RMSF), Radius of Gyration (RoG), Potential energy
and Intermolecular Hydrogen Bonding interactions. Finally, a
Principal Component Analysis (PCA) was performed for all the
protein–protein complex trajectories (global motions) obtained
from the Gromacs package, using the Essential Dynamics (ED)
approach to reduce data complexity and extract the simula-
tion’s concerted and biologically significant motion. This
motion is pivotal to, necessarily correlated with, and meaning-
ful for the complex’s biological function. Finally, a manual
inspection, using the PyMOL programme (Rother, 2005), was
made to visualise the crucial residues and intermolecular inter-
actions occurring between the two proteins in a predicted pro-
tein–protein complex.
2.2. In vitro analyses
2.2.1. Mass spectrometry-based protein–protein inter-
action analysis—multimer analysis
2.2.1.1. Instrumentation and proteins. In silico predictions
were validated by performing in vitro studies on one of the
protein–protein complexes, namely GST-M1–MAPK8 since
this complex exhibited significant binding affinity and
stronger structural stability in comparison with others.
Measurements were made using an Autoflex II Matrix-
Assisted Laser Desorption Ionization–Time-of-Flight
(MALDI–TOF) mass spectrometer (Bruker) (Supporting
Information, Method 2) equipped with CovalX’s HM4 inter-
action module (CovalX AG, Switzerland). The module con-
tains a special detection system designed to optimise
detection up to 2 MDa with nano-molar sensitivity. The
in vitro investigations used pure GST-M1 (23.6 kDa), GST-T1
(31.5 kDa) and MAPK8 (50.5 kDa) recombinant human pro-
teins (PROSPEC).
2.2.1.2. Crosslinking experiments. For control experiments,
20 lL of each protein sample, with >85–90% purity (GST-M1,
GST-T1 and MAPK8) were pipetted into eight dilution con-
centrations ranging from 1.96 to 250lg/L with a final vol-
ume of 10 lL. Onemicrolitre of each dilution was mixed with
1 lL of a matrix composed of a re-crystallised sinapinic acid
(10mg/mL) in acetonitrile/water (1:1, v/v) and trifluoroacetic
acid 0.1% (K200 MALDI Kit). After mixing, 1 lL of each sam-
ple was spotted on a MALDI plate (SCOUT 384). After evapor-
ation at room temperature, the plate was introduced into
the MALDI mass spectrometer and analysed immediately in
High-Mass MALDI mode. Analyses were done in triplicates.
Each mixture prepared for the aforementioned control
experiment (9lL) underwent crosslinking using CovalX’s
K200 MALDI MS analysis kit (CovalX, Switzerland). The pro-
tein solutions (concentration ranges are reported in the
Supporting Information, Method 2) were mixed with 1 lL of
K200 stabiliser reagent (2mg/mL) and incubated at room
temperature. After incubation (180min), samples were pre-
pared for MALDI analysis as the control experiments had
been. The samples were analysed using High-Mass MALDI
MS immediately after evaporation. The MALDI–ToF MS ana-
lysis was performed using CovalX’s HM4 interaction module,
with a standard nitrogen laser and focusing on different
mass ranges from 0 to 1500 kDa (analysis parameters used
are given in the Supporting Information, Method 2).
2.2.1.3. Characterization of the GST-M1/GST-T1 and GST-
M1/MAPK8 protein complexes. Mixtures of GST-M1 and
GST-T1 and of GST-M1 and MAPK8 were prepared with the
concentrations, (detailed in Supporting Information, Method
2). Onemicrolitre of the mixture obtained was mixed with
1 lL of a matrix composed of a re-crystallised sinapinic acid
matrix (10mg/mL) in acetonitrile/water (1:1, v/v) and tri-
fluoroacetic acid 0.1% (K200 MALDI Kit). After mixing, 1 lL of
each sample was spotted on the MALDI plate (SCOUT 384),
and following evaporation at room temperature, the plate
was introduced into the MALDI mass spectrometer and ana-
lysed immediately. Analyses were repeated in triplicate.
An external calibration of the instrument was made using
clusters of insulin, bovine serum albumin and immunoglobu-
lin G. Three spots were analysed from each sample (300 laser
shots per spot). The presented spectrum corresponds to the
sum of 300 laser shots. The mass spectrometry data were
analysed using CovalX’s Complex Tracker analysis software,
version 2.0 (CovalX, Switzerland).
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3. Results and discussion
3.1. Comparative protein sequence alignment and
phylogenetic analysis
The Protein sequence analysis was used to evaluate the
properties of selected seven cytosolic GST isoforms such as,
molecular weight, isoelectric point, amino acid composition,
instability index, aliphatic index, half-life, extinction coeffi-
cient. The result obtained from this analysis is given in the
Supporting Information (Tables S9 and S10). Interestingly,
GST-T1’s aliphatic index and GRAVY score were higher than
those predicted for the other proteins (see results in
Supporting Information Tables S11 and S12).The phylogen-
etic analysis of the GSTs identified 249 presumed functional
sites, out of which, we observed 19 conserved, 212 variable,
52 singleton and 158 parsimony-informative sites. The infor-
mation on conserved sites and variable sites was used to
construct a phylogenetic tree, based on the UPGMA and NJ
methods. Singleton sites and parsimony-informative sites are
useful for constructing a phylogenetic tree relying on charac-
ter-based approaches, namely MP and ME methods. This
phylogenetic analysis provided valuable insights into the
sequence similarity, sequence identity, conservation and
divergence present among the selected seven cytosolic GST
isoforms. We chose four phylogenetic analysis methods to
achieve more reliable evolutionary detail in terms of pairwise
distances: the identification of a group or clade, the identifi-
cation of subgroups or sister clades, the measurement of
overall mean distances or overall mean average, and similar-
ity statistics among the seven cytosolic GST isoforms (Figure
2). We observed high sequence similarity or sequence hom-
ology between those isoforms, as reported previously
(Nebert & Vasiliou, 2004). The overall evolutionary distance
between these seven GST isoforms was found to be 1.246
(Figure 2). We observed significant pairwise distances (strong
sequence similarities) between the GST isoforms (Supporting
Information, Table S8), leading us to form two subgroups,
namely subgroup1 (GST-A1, GST-A2 and GST-P1) and sub-
group2 (GST-M1, GST-M2 and GST-M5). As expected, the typ-
ical N and C terminal domains were identified in all the
isoforms. The GST-T1 isoform diverged completely from the
other six GST isoforms on this phylogenetic tree. Overall, the
phylogenetic analysis revealed higher sequence identity and
significant pairwise distances between the seven selected
GST isoforms, but less divergence was observed among the
selected seven cytosolic GST isoforms (Supporting
Information, Table S8). Phylogenetic analyses indicated that
it is most likely that the activities of GST-P1 would be taken
care by GST-M1, GST-M5, GST-M2 followed by GST-A1 or
GST-A2 isoforms, whenever there is less abundance or dys-
functional GST-P1 and vice versa. Overlapping substrate spe-
cificities would also be explained by these analyses. It is
possible that it is the quantity, localization of a specific iso-
form but not substrate specificities that could determine its
conjugating capacities or other functional roles. Thus, genetic
variants in some of these isoforms are more important owing
to their abundance in certain tissues, for example, GST-A1 in
liver and testes, GST-M5 in ovary and breast (Uhlen
et al., 2015).(ML)
A comparative protein sequence alignment of 16 MAP
kinases (Supporting Information, Figure S1) revealed 44 con-
served, 822 variable, 352 parsimony-informative and 345
singleton sites out of 1543 putative functional sites.
Interestingly, the 44 conserved sites were mainly in the kin-
ase domain of MAP kinases, revealing most of the common
catalytic residues present in the MAP kinase family. The the-
oretical isoelectric point (IEP) was below pH 7 for all the fam-
ily members except MAPK13, MAPK15 and NLK, indicating a
higher number of basic amino acid residues for these family
members (Supporting Information, Tables S12 and S13). The
Figure 2. Phylogenetic analysis of seven human glutathione S-transferase isoforms using four different methods: (a) Unweighted pair-group mean average
(UPGMA), (b) Neighbour-joining (NJ), (c) Minimum evolution (ME) and (d) Maximum parsimony (MP). Each isoform’s UniProt accession number is also shown.
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overall mean distance between the MAPK family members
was 1.02, suggesting that this lower divergence was because
most of the residues found in the catalytic domain are con-
served. Results indicated that MAPK9 and MAPK10 are closer
to MAPK8 (or JNK1), whereas MAPK6 and MAPK4 are closer
to ASK1. In this report, we suggest that both MAPK8 and
ASK1 interact with GST isoforms and, based on the results
obtained from the phylogenetic analysis, that MAPK4,
MAPK6, MAPK9 and MAPK10 (Supporting Information,
Figures S2 and S3) may interact with GST isoforms. However,
further in silico and in vitro studies will be necessary to con-
firm this hypothesis.
3.2. In silico analysis of protein–protein interactions
between GSTs and MAPK8 and ASK1
Analysis of the estimated free energy of binding (DG computed
using PRODIGY for predicted protein–protein complexes) of the
GSTs with MAPK8 showed that members of subgroup2—GST-
M isoforms: GST-M1 (–14.1 kcal/mol), GST-M2 (–15.7 kcal/mol)
and GST-M5 (–16.8 kcal/mol)—and an outlier,GST-T1
(–13.5 kcal/mol), exhibited higher binding affinities to MAPK8’s
kinase domain than did the other members of the GST family
(Tables 2 and 3). Regarding other GST–ASK1 interactions, bind-
ing affinities followed the order: GST-A1 (–17.1 kcal/mol)> GST-
M5 (–15.4 kcal/mol) > GST-A2 (–15.1 kcal/mol) > GST-M1
(–14.9 kcal/mol) > GST-M2 (–14.4 kcal/mol), GST-P1 (–14.4 kcal/
mol) > GST-T1 (–11.7 kcal/mol) (Tables 2 and 3). These observa-
tions indicated that when all the GST isoforms are abundant in
similar molar ratios, members of subgroup 2 on GST’s phylo-
genetic tree (GST Mu family members)—especially GST-M1, fol-
lowed by GST-T1—would exhibit a greater tendency to interact
with the MAPK8 protein. Similarly, GST-A1 isoforms would pre-
fer to interact with ASK1 protein; however, this interaction is
subject to regulation by the tissue-specific expression of GST
isoforms (Wang et al., 2000).
Under circumstances where cells contain lower levels of
MAPK8 or ASK1, GSTs would preferentially undergo homo-
dimerisation or hetero-dimerisation with other members.
Regarding GST-M1’s binding affinity with other GST family
members, protein–protein docking results suggested the fol-
lowing order: GST-A1 (–14.5 kcal/mol) > GST-T1 (–14.3 kcal/
mol) > GST-A2 (–13.7 kcal/mol) > GST-P1 (–12.7 kcal/mol) >
GST-M2 (–11.9 kcal/mol) (Supporting Information Tables S13
and S14). Details of the intramolecular interactions are given
in the Supporting Information (Table S15).
Whereas protein–protein docking is a semi-flexible
approach, in which one protein is fixed and the other is flex-
ible around it, MD simulation can mimic the protein–protein
complex’s physiological function, thus explaining the com-
plex’s behaviour in the presence of an aqueous environment.
The predicted protein–protein docking complexes, thus,
obtained were subjected to MD simulation to understand
their long-term structural stability, integrity, compactness
and protein folding properties. Together, the results of pro-
tein–protein docking and the MD simulation of GSTs and
MAPK8 revealed that—interestingly and in comparison, with
other isoforms—GST-M1 had the greatest binding affinity
and strongest structural stability with MAPK8 (Table 4). In
contrast, MD simulation of GSTs and ASK1 demonstrated
that GST-T1 showed the greatest structural stability with
ASK1 (Table 4). These MD simulations suggested that MAPK8
and ASK1 could be the most promising partners for inter-
action with GST-M1 and GST-T1, respectively. Other isoforms
also showed reasonable binding affinity and structural stabil-
ity towards these two interacting partners, however.
The MD simulations of GSTs withMAPK8 and of GSTs with
ASK1 are given in the Supporting Information (Figures
S4–S12). To understand the key structural details in terms of
stability, integrity, compactness and folding properties, we
now discuss the GST-M1–MAPK8 and GST-T1–ASK1 complexes.
RMSD and RMSF analyses shed light on the structural stability
and flexibility of the protein-protein complexes, respectively.
The GST-M1–MAPK8 complex had the lowest average RMSD
(0.167 nm; Table 4), and RMSF values (0.110 nm) suggesting
stronger structural stability, lower flexibility than other com-
plexes (Supporting Information Figures S11 and S12) high-
lighting significant interaction of GST-M1 with the kinase
domain of MAPK8.The GST-M1–MAPK8 complex attained the
stabilisation state after 5000 ps (5 ns), and it maintained its
structural stability until the end of the 20 ns in comparison
Table 2. Docking score, estimated free energy of binding (DG) and estimated
binding affinity (Kd) of GSTs with the MAPK8 and ASK1 complexes, obtained
from the HADDOCK and PRODIGY web servers.
Protein–Protein complex HADDOCK score Binding affinity
DG (kcal/mol) Kd (M)
Seven GST isoforms with MAPK8
GST-A1:MAPK8 –83.7 þ/6.2 –10.1 7.3e–08
GST-A2:MAPK8 –76.6 þ/10.4 –13.3 4.4e–10
GST-M1:MAPK8 –105.7 þ/20.1 –14.1 1.2e–10
GST-M2:MAPK8 –159.0 þ/20.2 –15.7 7.9e–12
GST-M5:MAPK8 –151.7 þ/6.8 –16.8 1.4e–12
GST-P1:MAPK8 –86.6 þ/8.3 –13.3 4.5e–10
GST-T1:MAPK8 –91.8 þ/7.7 –13.5 3.3e–10
Seven GST isoforms with ASK1
GST-A1:ASK1 86.5 þ/9.1 17.4 5.0e–13
GST-A2:ASK1 93.3 þ/18.8 15.1 2.4e–11
GST-M1:ASK1 68.3 þ/11.0 14.9 3.2e–11
GST-M2:ASK1 92.9 þ/7.1 14.4 7.2e–11
GST-M5:ASK1 130.1 þ/19.6 15.4 1.4e–11
GST-P1:ASK1 66.3 þ/9.7 14.4 6.9e–11
GST-T1:ASK1 44.3 þ/9.0 11.7 5.5e–09
Table 3. Analysis of the intermolecular interactions of the protein–protein
complexes formed by the seven GST isoforms with MAPK8 protein and
with ASK1.
Intermolecular interactions of GSTs with MAPK8
Salt bridges H bonds Nonbonded contacts
GST-A1:MAPK8 – 10 181
GST-A2:MAPK8 4 18 243
GST-M1:MAPK8 7 18 220
GST-M2:MAPK8 6 20 274
GST-M5:MAPK8 4 12 247
GST-P1:MAPK8 3 15 181
GST-T1:MAPK8 8 19 223
Intermolecular interactions of GSTs with ASK1
GST-A1:ASK1 8 21 267
GST-A2:ASK1 5 15 262
GST-M1:ASK1 5 19 255
GST-M2:ASK1 3 17 168
GST-M5:ASK1 8 26 266
GST-P1:ASK1 2 21 275
GST-T1:ASK1 7 22 240
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with other complexes. The GST-M1–MAPK8 complex also
showed low average RoG values (2.46 nm), i.e. better than the
other complexes (Table 4 and Figure 3). The GST-M1–MAPK8’s
RoG profile was similar until 10 ns, but the profile was altered
due to conformational changes. However, the GST-M1–MAPK8
complex’s potential energy is slightly higher because of the
presence of loop or coil elements in the structure of GST-M1
or MAPK8. Moreover, in addition to global dynamics, PCA (or
essential dynamics) was used to capture the relative biologic-
ally significant motion based on global trajectories. The GST-
M1–MAPK8 complex displayed a lower trace of covariance
matrix value (169.265 nm2) than the other complexes. Lower
trace of covariance matrix value indicates that the complex is
stable at the same time flexibility is also lower, hence, this
particular complex occupied the lesser region in the conform-
ational space. The results obtained from RMSD, RMSF and RoG
analyses were consistent with the results of PCA (or essential
dynamics) results of GST-M1–MAPK8. All these observations
suggested that GST-M1 had a strong binding affinity and
higher structural stability with MAPK8. On the other hand, MD
simulations of GSTs with ASK1 revealed no vast differences
between the seven GST isoform–ASK1 complexes (Table
4).The results from these analyses suggested that most of the
isoforms could interact with ASK1. However, the GST-T1–ASK1
complex had lower covariance matrix values (235.815 nm2), as
revealed using PCA, and this complex had a consistent struc-
tural pattern (Figure 4). In contrast, the average RMSD (0.22 to
0.27 nm),RMSF (0.132 to 0.181 nm) and RoG values (2.65 to












Seven GST isoforms with MAPK8
GST-A1:MAPK8 0.184 0.126 2.49 –1,651,292.5 199.05
GST-A2:MAPK8 0.228 0.119 2.69 –1,998,776.75 188.292
GST-M1:MAPK8 0.167 0.110 2.46 –1,262,919.75 169.265
GST-M2:MAPK8 0.228 0.125 2.51 –1,625,000.375 192.007
GST-M5:MAPK8 0.225 0.116 2.46 –1,367,582.375 174.945
GST-P1:MAPK8 0.156 0.121 2.53 –1,585,577.125 183.181
GST-T1:MAPK8 0.231 0.148 2.65 –1,901,880.75 270.803
Seven GST isoforms with ASK1
GST-A1:ASK1 0.22 0.135 2.65 –1,908,568.875 244.06
GST-A2:ASK1 0.27 0.143 2.63 –1,587,740 278.932
GST-M1:ASK1 0.27 0.153 2.74 –1,954,723.375 301.066
GST-M2:ASK1 0.3 0.181 2.93 –2,066,349.25 442.799
GST-M5:ASK1 0.22 0.151 2.70 –1,895,464.75 292.549
GST-P1:ASK1 0.25 0.138 2.67 –1,783,174.5 246.417
GST-T1:ASK1 0.22 0.132 2.79 –1,922,931.375 235.815
Figure 3. MD simulation results for GST-M1 with MAPK8: (a) Root Mean Square Deviation (RMSD), (b) Radius of Gyration (RoG), (c) Potential Energy and (d)
Principal Component Analysis (PCA). (X-axis: time in graphs (a), (b) and (c). Y-axis: values for (a) RMSD, (b) RoG and (c) Potential energy. For graph (d), X-axis: princi-
pal component 1 and Y-axis: principal component 2.
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2.74 nm) for most of the complexes were similar, except for
GST-M2 which showed significantly higher average RMSD
(0.3 nm), RoG (2.93 nm) values but higher RMSF value
(0.181 nm) indicating higher flexibility of this complex.
Protein–protein docking (Figure 5) and global and essential
dynamics analyses supported the idea that GST-A1, GST-P1
and GST-T1 isoforms might actively interact with ASK1, with
slightly more certainty for GST-T1. However, further experi-
mental studies will be required to validate this hypothesis.
The kinase domains of MAPK8 and ASK1 proteins interacted
in particular with the hydrophobic sites (H-sites) of the
seven GST isoforms. The residues found in GST’s H-sites and
MAPK kinase domains play an important role in determin-
ing the intermolecular interactions between GSTs and
MAPKs. Details of the GSTs’ interacting residues are given
in the Supporting Information Tables S16–S30). The pre-
dicted hotspot residues of GSTs from in silico alanine scan-
ning mutagenesis are mostly involved in the intermolecular
interaction with MAPK8 and ASK1. Higher numbers of inter-
face residues were predicted for GST-M1 isoform from the
GST-M1–MAPK8 complex, whereas nearly similar numbers
of interface residues were predicted for all seven GST iso-
form complexes with ASK1 Supporting Information
(Tables S16–S30).
Figure 4. MD simulation results for GST-T1 with ASK1, (a) RMSD, (b) Radius of Gyration, (c) Potential Energy and (d) Principal Component Analysis (X-axis: time in
(a), (b) and (c). Y-axis: values for graphs (a) RMSD, (b) RoG and (c) Potential energy. For graph (d), X-axis: principal component 1 and Y-axis: principal component 2.
Figure 5. Predicted protein–protein complex obtained from HADDOCK’s easy interface. (a) GST-M1–MAPK8 complex and (b) GST-T1–ASK1 complex. Hydrophobic
sites of GSTs interact with MAPK8’s kinase domain and with ASK1.
8 C. R. S. UPPUGUNDURI ET AL.
3.3. In vitro protein–protein interaction analyses using
MALDI-TOF
In silico predictions suggested that GST-M1 and GST-T1
exhibited higher binding affinities and stronger structural sta-
bility with MAPK8 and ASK1, respectively. However, the pre-
dictions for GST-M1–MAPK8 interaction were better than for
GST-T1–ASK1. Thus, to validate these computational predic-
tions, we performed crosslinking and mass spectroscopy
studies on GST-M1–MAPK8. Interestingly, the results obtained
from in silico predictions are consistent with in vitro studies.
In vitro interactions mixed GST-M1 with GST-T1 and GST-M1
with MAPK8. The peak masses (observed molecular weights)
of the controls and the crosslinking experiments are detailed
in the Supporting Information (Table S31). In separate cross-
linking experiments, GST-M1 showed no noncovalent com-
plexes at the higher molecular weights that could have
represented homo-oligomers, whereas GST-T1 showed peaks
representing monomeric, dimeric, tetrameric and hexameric
forms (Supporting Information, Figures S13–S17). In crosslink-
ing experiments comprising GST-M1 and GST-T1, peaks cor-
responding to monomers of both proteins, GST-T1
homodimers, GST-M1–2GST-T1 trimers and GST-T1 homo tet-
ramers were detected (Supporting Information, Figures
S13–S17). Upon testing the interaction between GST-M1 and
MAPK8 in crosslinking experiments, we observed a peak cor-
responding to a dimer composed of both proteins
(Supporting Information, Figures S13–S17). These results
agree with the protein–protein docking and MD simulation
predictions for GST-M1–MAPK8 complex, i.e. greater binding
affinity and stronger structural stability. However, we did not
map the residues involved in the interaction using in vitro
methods. Mapping the residues experimentally using techni-
ques such as Cross-Linking Mass Spectrometry (XLMS) and
Hydrogen deuterium exchange mass spectrometry (HDXMS),
would confirm the in silico predictions, but not under the
purview of the current investigation which is aimed at identi-
fying the presence or absence and readiness of GST isoforms
for interaction with MAPK8 and ASK1. Future experimental
studies are necessary in order to map the residues involved
in the interaction.
The results showed that in vitro testing at very low con-
centrations could provide insights into noncovalent interac-
tions between two proteins of interest; the crosslinking
experiments showed evidence that GSTs can form homo or
heterodimers, trimers and tetramers. Together, they thus pro-
vided a proof-of-principle strategy for protein–protein inter-
action predictions in silico, followed by in vitro testing before
the initiation of more complex, expensive and time-consum-
ing experimental studies.
3.4. The interpretation of in silico and in vitro
protein–protein interactions
Both MAPK8 and ASK1 are essential elements in the JNK
(Jun-N-terminal kinase) signalling pathway that is activated
by electrophile-induced stress (e.g. by busulfan) (Adler et al.,
1999; Ma et al., 2014). Under normal conditions, activation of
ASK1 results in moderate levels of JNK signalling, and this
apoptotic pathway is opposed by the PI3K/AKT (phosphoino-
sitide-3-kinase) and NF-KB (nuclear factor kappa-light-chain-
enhancer of activated B cells) pathways that promote cellular
proliferation (Tobiume et al., 2001). GSTs, thioredoxins may
interfere with the activation of JNK directly or indirectly by
inhibiting ASK1. These direct or indirect means of inhibition
would thus modulate the apoptosis due to electrophile-
induced stress. The availability of interacting GST isoforms
may vary due to either their participation in the detoxifica-
tion of electrophiles or their genetic variants (gene deletions,
variants regulating expression) or tissue-specific expression.
GSTs most likely regulate JNK pathway activation by modu-
lating the phosphorylation of MAPK8 and ASK1 (Adler et al.,
1999). Electrophilic compounds may activate ASK1, possibly
by dissociating the GST–ASK1 complexes and the TrX or GPx
complexes of ASK1. Considering the sequential activation of
JNK1 upon activation by ASK1, we assume that the deactiva-
tion of ASK1 is efficient in the prevention of apoptosis,
whereas JNK deactivation might be saturated when there is
constant ASK1 activation due to electrophile-induced stress.
Thus, preventing the ASK1 activation that is essential for
JNK1 activation would prevent the apoptosis of cells under
oxidative stress. These observations highlight the importance
of GST-T1 null alleles and M1 null alleles, and the amount of
proteins in the cytosol, in their role of modulating ASK1–JNK
activation-induced apoptosis following electrophile-induced
stress. Based on these observations, it is assumed that there
is constant activation of JNK in the absence of both these
proteins. This result in the cellular apoptosis that is the pos-
sible scenario in NULL carriers of these two proteins on
exposure to electrophiles. Hence, the deletion of both GST-
M1 and GST-T1 might promote apoptosis via the constant
activation of ASK1 and JNK1. However, these cells would
likely adopt alternate mechanisms to avoid apoptosis due to
the activation of ASK1 and JNK1 in the absence of GST-M1
and GST-T1, respectively. Our laboratory is currently using
lentiviral systems to investigate this aspect by expressing
GST-M1 and GST-T1 isoforms in cells that lack these proteins.
This would help us to understand the phosphorylation status
of ASK1 and JNK1 in the absence of the GST-M1 and GST-T1
isoforms, respectively, and vice versa. Alternatively, using
GST inhibitors might also provide evidence for
this hypothesis.
The interaction between MAPK8 and GST-M1 and ASK1
and GSTs may also affect GST catalytic activity, potentially
affecting the elimination of toxic electrophilic compounds.
Crystal structure of GST-M1 structure complexed with gluta-
thione (Patskovsky et al., 2000, 2006) and GST-T1 complexed
with S-hexyl-glutathione (Tars et al., 2006) indicated that resi-
dues crucial for the GST activity are part of the interface with
MAPK8 and ASK1, respectively, predicted with our in silico
analysis. Based on the results obtained from this study, the
activity of GSTs may be altered due to the interaction with
MAPK8 and with ASK1. On the other hand, following binding
of interaction partner, for example, MAPK8, to GST-M1, the
conformation of H-Site and structure of GSTs may also
change that might increase the GST activity. However, this
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need to be tested in future using GST pure proteins in the
presence of interacting partners using 1-chloro-2,4-dinitro-
benzene as a GST substrate (Robin et al., 2020).
Further experimental studies are always necessary to con-
firm any significant changes to GST activity. Moreover, our
future work is directed towards understanding the structural
and functional changes of GSTs when complexed with that
of MAPK8 and ASK1.
4. Conclusion
The present study reported the protein–protein interactions
of the seven most abundant cytosolic GST isoforms—GST
alpha-1 (GST-A1), GST alpha-2 (GST-A2), GST mu-1 (GST-M1),
GST mu-2 (GST-M2), GST mu-5 (GST-M5), GST theta-1 (GST-
T1) and GST pi-1 (GST-P1)—with MAPK8 and with ASK1 using
a combination of in silico and in vitro experiments. In silico
predictions indicated that GST-M1 had a higher binding affin-
ity to MAPK8, and the complex formed by these two pro-
teins was stable according to MD simulations. No great
differences were observed between the seven GST isoforms
and ASK1 in MD simulation: all seven isoforms interacted
with ASK1 with similar affinities; however, the GST-T1–ASK1
complex’s structural flexibility was far weaker than that of
the other six GSTs. This systematic approach could serve as
the basis for many other protein–protein interaction studies
attempting to identify the interacting protein partners in
other drug-metabolising enzymes.
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